0001387131-22-010043.txt : 20220927 0001387131-22-010043.hdr.sgml : 20220927 20220927174640 ACCESSION NUMBER: 0001387131-22-010043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220923 FILED AS OF DATE: 20220927 DATE AS OF CHANGE: 20220927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danahy Kevin Patrick CENTRAL INDEX KEY: 0001913245 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 221272306 MAIL ADDRESS: STREET 1: 50 TEABERRY LANE CITY: BRAINTREE STATE: MA ZIP: 02184 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 4 1 danahy-form4_092722.xml FORM 4 X0306 4 2022-09-23 0 0001625101 Pulse Biosciences, Inc. PLSE 0001913245 Danahy Kevin Patrick C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY HAYWARD CA 94545 0 1 0 0 Chief Executive Officer Stock Option (right to buy) 1.53 2022-09-23 4 A 0 450000 A 2032-09-23 Common Stock 450000 450000 D The option was granted on September 23, 2022 under the Issuer's 2017 Equity Incentive Plan and pursuant to an amendment to the Reporting Person's employment agreement. The shares will vest in four equal annual installments on each of the first four annual anniversaries of the grant date, subject to the Reporting Person's continued service through each vesting date. Not applicable. /s/ Kenneth B. Stratton, as Attorney-in-Fact 2022-09-27